| Basics |
PERRIGO COMPANY PLC
Perrigo Co PLC is a healthcare company providing branded OTC products throughout Europe and the USA. It sells its products primarily in North America and Europe, as well as in other markets, including Australia, Israel and China.
|
| IPO Date: |
December 17, 1991 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$3.76B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.74 | 1.23%
|
| Avg Daily Range (30 D): |
$0.31 | 1.18%
|
| Avg Daily Range (90 D): |
$0.38 | 1.44%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.04M |
| Avg Daily Volume (30 D): |
1.02M |
| Avg Daily Volume (90 D): |
1.24M |
| Trade Size |
| Avg Trade Size (Sh.): |
107 |
| Avg Trade Size (Sh.) (30 D): |
62 |
| Avg Trade Size (Sh.) (90 D): |
66 |
| Institutional Trades |
| Total Inst.Trades: |
17,183 |
| Avg Inst. Trade: |
$3.49M |
| Avg Inst. Trade (30 D): |
$4.39M |
| Avg Inst. Trade (90 D): |
$3.51M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$6.87M |
| Avg Closing Trade (30 D): |
$6.07M |
| Avg Closing Trade (90 D): |
$6.81M |
| Avg Closing Volume: |
112.7K |
|
|
|
|
| Financials |
| |
TTM |
Q4 2024 |
FY 2024 |
|
Basic EPS
|
$-.05
|
$-.32
|
$-1.25
|
|
Diluted EPS
|
$-.05
|
$-.32
|
$-1.25
|
|
Revenue
|
$ 1.04B
|
$ 1.14B
|
$ 4.37B
|
|
Gross Profit
|
$ 392.3M
|
$ 385.9M
|
$ 1.54B
|
|
Net Income / Loss
|
$ -6.4M
|
$ -44.5M
|
$ -171.8M
|
|
Operating Income / Loss
|
$ 46.9M
|
$ 114.2M
|
$ 112.9M
|
|
Cost of Revenue
|
$ 651.6M
|
$ 752.4M
|
$ 2.83B
|
|
Net Cash Flow
|
$ -141.7M
|
$ -904.7M
|
$ -192.5M
|
|
PE Ratio
|
|
|
|
|
